# Sleep Number Corp: Form 10-Q for the period ended Apr 4, 2026

- Company: [Sleep Number Corp](/companies/snbrq.md) (CIK 827187)
- Form: 10-Q
- Filed: 2026-05-12
- Accepted by EDGAR: May 12, 2026, 07:06 ET
- Period: 2026-04-04
- Accession: 0000827187-26-000041
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/827187/000082718726000041/snbr-20260404.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/827187/000082718726000041/

## Figures reported in this filing

Standardized XBRL line items for the period ended 2026-04-04.

| Line item | Period | Value | XBRL concept |
| --- | --- | ---: | --- |
| Revenue | 3 months, 2026-01-04 to 2026-04-04 | $319.0m | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Cost of revenue | 3 months, 2026-01-04 to 2026-04-04 | $134.4m | us-gaap:CostOfRevenue |
| Gross profit | 3 months, 2026-01-04 to 2026-04-04 | $184.6m | us-gaap:GrossProfit |
| Research and development | 3 months, 2026-01-04 to 2026-04-04 | $5.3m | us-gaap:ResearchAndDevelopmentExpense |
| Operating income | 3 months, 2026-01-04 to 2026-04-04 | −$36.9m | us-gaap:OperatingIncomeLoss |
| Interest expense | 3 months, 2026-01-04 to 2026-04-04 | $13.1m | us-gaap:InterestExpenseNonoperating |
| Income tax | 3 months, 2026-01-04 to 2026-04-04 | $338.0k | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months, 2026-01-04 to 2026-04-04 | −$50.3m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months, 2026-01-04 to 2026-04-04 | −$2.19 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months, 2026-01-04 to 2026-04-04 | −$2.19 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months, 2026-01-04 to 2026-04-04 | 22,991,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 3 months, 2026-01-04 to 2026-04-04 | −$7.8m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 3 months, 2026-01-04 to 2026-04-04 | $5.4m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Share repurchases | 3 months, 2026-01-04 to 2026-04-04 | $373.0k | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Cash and equivalents | at 2026-04-04 | $1.5m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | at 2026-04-04 | $143.5m | us-gaap:AssetsCurrent |
| Total assets | at 2026-04-04 | $641.0m | us-gaap:Assets |
| Current liabilities | at 2026-04-04 | $931.7m | us-gaap:LiabilitiesCurrent |
| Total liabilities | at 2026-04-04 | $1.27bn | us-gaap:Liabilities |
| Current portion of debt | at 2026-04-04 | $605.6m | us-gaap:DebtCurrent |
| Shareholders' equity | at 2026-04-04 | −$626.3m | us-gaap:StockholdersEquity |
| Shares outstanding | at 2026-04-04 | 23,049,000 shares | dei:EntityCommonStockSharesOutstanding |

## Management's discussion and analysis

As filed, 44,143 characters.

### OPERATIONS

Management’s Discussion and Analysis of Financial Condition and Results of Operations (MD&A) is intended to provide a

reader of the Company’s condensed consolidated financial statements with a narrative from the perspective of

management on its financial condition, results of operations, liquidity and certain other factors that may affect the

Company’s future results. MD&A is presented in seven sections:

- Forward-Looking Statements and Risk Factors
- Business Overview
- Results of Operations
- Liquidity and Capital Resources
- Non-GAAP Data Reconciliations
- Critical Accounting Policies

### Forward-looking Statements and Risk Factors

### The discussion in this Quarterly Report on Form 10-Q contains certain forward-looking statements that relate to

### future plans, events, financial results or performance. You can identify forward-looking statements by those that

### are not historical in nature, particularly those that use terminology such as “may,” “will,” “should,” “could,”

### “expect,” “anticipate,” “believe,” “estimate,” “plan,” “project,” “predict,” “intend,” “potential,” “continue” or the

### negative of these or similar terms. These statements are subject to certain risks and uncertainties that could

### cause actual results to differ materially from the Company’s historical experience and its present expectations or

### projections. These risks and uncertainties include, among others:

- Changes in economic conditions and consumer sentiment and related impacts on discretionary consumer spending;
- Interest rates remain elevated, and may further increase and impact the cost of servicing the Company’s

indebtedness;

- Availability of attractive and cost-effective consumer credit options;
- Ability to achieve the improvements, growth, cost-savings, efficiencies and other benefits related to its turnaround

strategy to avoid adverse effects and the costs to implement its turnaround strategy;

- Ability to continue as a going concern;
- Access to additional capital and its access to such capital or alternative financing options may depend on factors

beyond the Company’s control or require the Company to accept unfavorable terms;

- Ability to manage the Company’s credit agreement, which contains financial covenants and other restrictions on our

actions;

- Effectiveness and efficiency of the Company’s marketing strategy and promotions;
- Ability to execute Sleep Number’s Total Retail distribution strategy;
- Ability to compete effectively;
- Ability to achieve and maintain high levels of product and service quality;
- Ability to improve and expand the product line, anticipate and respond to changing consumer trends, and execute new

product introductions;

- Ability to protect the Company’s technology, trademarks and brand, and the adequacy of its intellectual property

rights;

- Dependence on, and ability to maintain working relationships with key suppliers and third parties, including some that

are the only source of supply or services currently used by the Company;

- Fluctuations in commodity prices or third-party delivery or logistics costs and other inflationary pressures;
- Risks inherent in global-sourcing activities, including tariffs, foreign regulation, geo-political turmoil, war, pandemics,

labor challenges, foreign currency fluctuations, inflation, climate or other disasters and resulting supply shortages, and

production and delivery delays and disruptions;

- Operating with minimal levels of inventory, which may leave the Company vulnerable to supply shortages;

### 16 \| 1Q 2026 FORM 10-Q SLEEP NUMBER CORPORATION

- Risks of disruption in the operation of any of the Company’s facilities and operations, including manufacturing,

assembly, distribution, logistics, field services, home delivery, headquarters, product development, retail or customer

service operations;

- Ability to effectively complete potential future acquisitions, business combinations or divestitures;
- Sleep Number’s ability, and the ability of its suppliers and vendors, to attract, retain and motivate qualified and

effective personnel;

- Ability to comply with existing and changing government regulations and laws;
- Ability to identify and withstand cyber threats that could compromise the security of the Company’s systems or those

of third parties upon which it relies and could result in a data breach or business disruption;

- Risks associated with advancements in, adoption of or the failure to effectively adopt, artificial intelligence and related

technologies;

- Adequacy of the Company’s and third-party information systems, and costs and disruptions related to upgrading or

maintaining these systems;

- Volatility of Sleep Number stock, its removal from various stock indices and the potential negative effects of

shareholder activism or of changes in coverage by securities analysts;

- Unfavorable tax treatment;
- Environmental, social and governance risks, including increasing scrutiny and evolving regulatory and stakeholder

expectations; and

- Ability to adapt to climate change and readiness for legal or regulatory responses thereto.

### Additional information concerning these, and other risks and uncertainties is contained under the caption “Risk

### Factors” in Part I, Item 1A. in the Company’s Annual Report on Form 10-K and in Part II. Item 1A. in subsequent

### Quarterly Reports on Form 10-Q.

The Company has no obligation to publicly update or revise any of the forward-looking statements contained in this

Quarterly Report on Form 10-Q.

### Business Overview

Sleep Number is the leader in personalized sleep wellness. Its mattresses are designed to evolve with each sleeper to

help them feel and perform their best. With adjustable firmness, pressure-relieving support and temperature balancing

comfort built into every mattress, Sleep Number beds adapt to customers’ changing needs, night after night, year after

year. Backed by over 40 years of innovation, over 1,000 patents and patents pending, and billions of hours of sleep data,

Sleep Number has helped more than 16 million people achieve their best sleep. The fully integrated model ensures quality,

durability, and care at every step—from design and craftsmanship to delivery and long-term support.

Sleep Number products are awarded the industry's top recognitions, including ranked #1 in customer satisfaction for

mattresses purchased in-store and online, and #1 in comfort, by J.D. Power. In addition, the company is the Official Sleep +

Wellness Partner of the NFL, marking a relationship that leverages players, team partnerships, and league-wide initiatives

to amplify brand awareness and drive consumer engagement. Sleep Number’s life-changing, differentiated smart

mattresses combine physical and digital innovations, integrating unparalleled physical comfort with a highly advanced

sleep wellness platform. The smart beds offer the Company’s signature firmness adjustability, enabling each sleeper

adjustable comfort. Embedded digital sensors learn the sleep needs of each individual; “sense and do” technology uses

the sensed data to automatically adjust the smart mattress to keep the sleeper comfortable throughout the night.

Temperature balancing technology supports the ideal climate for each sleeper and solves a prevalent sleep challenge.

Additionally, smart mattresses are an exceptional value, with personalized sleep insights delivered daily, new features

regularly added to all smart mattresses through over-the-air updates and prices to meet most budgets. Sleep Number’s

mattresses provide unmatched features, benefits and comfort that can lead to improved sleep health and wellness for

both sleepers.

The Company’s advantaged business model is supported by its consumer innovation strategy: an individualized, digital

sleep wellness platform, a network of millions of highly engaged Smart Sleepers who are loyal brand advocates, a

vertically integrated operating model and a team member culture of individuality.

The Company’s 3,000 mission-driven team members are focused on driving value creation, including our exclusive direct-

to-consumer selling in 577 stores and online, which meets customers whenever and wherever they choose to provide an

### 17 \| 1Q 2026 FORM 10-Q SLEEP NUMBER CORPORATION

exceptional experience and a lifelong relationship. Additionally, the Company partners with world-leading institutions to

bring the power of 40 billion hours of longitudinal sleep data to sleep science and research.

In November 2025, the Company introduced its turnaround strategy “Sleep Number Shifts,” a focused, company-wide

effort to reposition the brand, expand reach to new customer groups, and reignite growth. The aim is to drive value for

shareholders, customers and team members with efforts rooted in the consumer through all dimensions of the business.

It is centered on three key areas:

- **Product:** The Company is simplifying its offering with the goal of growing its customer base while building on the

demand from repeat customers

- **Marketing:** The Company is modernizing its efforts by expanding channels and reach with new creative to better

connect with today’s consumer and drive engagement with a focus on better ROI

- **Distribution:** The Company is focused on optimizing store footprint as well as exploring opportunities to expand

distribution into new channels, both physical and digital.

“Sleep Number Shifts” is being implemented as the Company continues to execute cost savings and operating

efficiencies, including real estate optimization and right-sizing the fixed cost base. While the Company is focused on

implementing the “Sleep Number Shifts” and executing cost savings and operating efficiencies, it faces liquidity

challenges.

### Results of Operations

#### Quarterly and Year-to-Date Results

Quarterly and year-to-date operating results may fluctuate significantly as a result of a variety of factors, including

increases or decreases in sales, timing, amount and effectiveness of advertising expenditures, changes in sales return

rates or warranty experience, timing of investments in growth initiatives and infrastructure, timing of store openings/

closings and related expenses, changes in net sales resulting from changes in the Company’s store base, timing of new

product introductions and related expenses, timing of promotional offerings, competitive factors, changes in commodity

costs, disruptions in global supplies or third-party service providers, seasonality of retail and bedding industry sales,

consumer sentiment and general economic conditions. The extent to which these external factors will impact the

Company’s business and its consolidated financial results will depend on future developments, which are highly uncertain

and cannot be predicted. Therefore, the historical results of operations may not be indicative of the results that may be

achieved for any future period.

#### Highlights

Financial highlights for the three months ended April 4, 2026 were as follows:

- Net sales for the three months ended April 4, 2026 decreased 19% to $319 million, compared with $393 million for the

same period one year ago. Demand was impacted by ongoing industry demand pressure and lower store traffic.

- The net sales change resulted from a 16% comparable sales decrease in Total Retail. For additional details, see the

components of total net sales change on page 19.

- Average sales per store (sales for stores open at least one year, Total Retail, including online, phone and chat) on a

trailing twelve-month basis for the period ended April 4, 2026 totaled $2.2 million, compared with $2.5 million for the

same period one year ago.

- Operating loss for the three months ended April 4, 2026 was $37 million, compared with operating income of

$2 million for the same period one year ago. The $39 million decrease in operating income was driven by the lower

gross profit, partially offset by a $17 million reduction in operating expenses. The Company’s first quarter operating

loss rate was impacted by the deleveraging impact of the 19% decrease in net sales.

- Adjusted EBITDA for the three months ended April 4, 2026 was $6 million, compared to $22 million for the same

period one year ago. The decrease was primarily due to higher net loss when compared to the same period one year

ago, partially offset by an increase restructuring costs and other non-recurring items. For additional details, see *Non-*

*GAAP Data Reconciliations* section on page 24.

- Gross profit margin of 57.9% for the three months ended April 4, 2026 compared to 61.2% for the same period one

year ago. See the gross profit discussion on page 20 for additional details.

### 18 \| 1Q 2026 FORM 10-Q SLEEP NUMBER CORPORATION

- The $17 million year-over-year reduction in the Company’s operating expenses was due to lower sales and marketing

expenses, general and administrative expenses, and research and development expenses, partially offset by higher

restructuring costs.

- Net loss for the three months ended April 4, 2026 was $50 million, compared with $9 million for the same period one

year ago. Net loss per diluted share was $2.19, compared with $0.38 for the same period one year ago.

- The Company’s adjusted return on invested capital (Adjusted ROIC) was negative 13.1% on a trailing twelve-month

basis for the period ended April 4, 2026, compared with 7.2% for the comparable period one year ago. For additional

details, see *Non-GAAP Data Reconciliations* section beginning on page 24.

- The Company used $8 million in cash from operating activities for the three months ended April 4, 2026, compared

with $3 million for the same period one year ago.

- Free cash flow used $13 million for the three months ended April 4, 2026, compared with $7 million used for the same

period one year ago. For additional details, see *Non-GAAP Data Reconciliations* section on page 24.

- As of April 4, 2026, the Company had $606 million of borrowings under its credit facility.

The following table sets forth the Company’s results of operations expressed as dollars and percentages of net sales.

Figures are in millions, except percentages and per share amounts. Amounts may not add due to rounding differences.

|  | Three Months Ended April 4, 2026 |  | March 29, 2025 |  |
| --- | ---: | ---: | ---: | ---: |
| Net sales | $319.0 | 100.0% | $393.3 | 100.0% |
| Cost of sales | 134.4 | 42.1% | 152.7 | 38.8% |
| Gross profit | 184.6 | 57.9% | 240.5 | 61.2% |
| Operating expenses: |  |  |  |  |
| Sales and marketing | 160.8 | 50.4% | 189.1 | 48.1% |
| General and administrative | 33.6 | 10.5% | 38.6 | 9.8% |
| Research and development | 5.3 | 1.7% | 10.9 | 2.8% |
| Restructuring costs | 21.7 | 6.8% | 0.1 | 0.0% |
| Total operating expenses | 221.5 | 69.4% | 238.7 | 60.7% |
| Operating (loss) income | (36.9) | (11.6%) | 1.9 | 0.5% |
| Interest expense, net | 13.1 | 4.1% | 11.1 | 2.8% |
| Loss before income taxes | (50.0) | (15.7%) | (9.2) | (2.3%) |
| Income tax expense (benefit) | 0.3 | 0.1% | (0.6) | (0.1%) |
| Net loss | $(50.3) | (15.8%) | $(8.6) | (2.2%) |
| Net loss per share: |  |  |  |  |
| Basic and diluted | $(2.19) |  | $(0.38) |  |
| Weighted-average number of common shares: |  |  |  |  |
| Basic and diluted | 23.0 |  | 22.7 |  |

The percentage of total net sales, by dollar volume, was as follows:

|  | Three Months Ended April 4, 2026 | March 29, 2025 |
| --- | ---: | ---: |
| Retail stores | 87.0% | 87.6% |
| Online, phone, chat and other | 13.0% | 12.4% |
| Total Company | 100.0% | 100.0% |

### 19 \| 1Q 2026 FORM 10-Q SLEEP NUMBER CORPORATION

The components of total net sales change, including comparable net sales changes, were as follows:

| Sales change rates: | Three Months Ended April 4, 2026 | March 29, 2025 |
| --- | ---: | ---: |
| Retail comparable-store sales (1) | (17%) | (15%) |
| Online, phone and chat | (15%) | (12%) |
| Total Retail comparable sales change (1) | (16%) | (15%) |
| Net opened/closed stores and other | (3%) | (1%) |
| Total Company | (19%) | (16%) |

(1) Stores are included in the comparable-store calculations in the 13th full month of operations. Stores that have been remodeled or repositioned within

the same shopping center remain in the comparable-store base.

Other sales metrics were as follows:

|  | Three Months Ended April 4, 2026 | March 29, 2025 |
| --- | ---: | ---: |
| Average sales per store (1) (in thousands) | $2,170 | $2,495 |
| Average sales per square foot (1) | $700 | $807 |
| Stores \> $2 million in net sales (2) | 31% | 51% |
| Stores \> $3 million in net sales (2) | 6% | 15% |
| Average revenue per mattress unit – Total Retail (3) | $6,021 | $5,992 |

(1) Trailing-twelve months Total Retail comparable sales per store open at least one year.

(2) Trailing-twelve months for stores open at least one year (excludes Online, Phone and Chat sales).

(3) Represents Total Retail net sales divided by Total Retail mattress units.

The number of retail stores operating was as follows:

|  | Three Months Ended April 4, 2026 | March 29, 2025 |
| --- | ---: | ---: |
| Beginning of period | 600 | 640 |
| Opened | — | 2 |
| Closed | (23) | (5) |
| End of period | 577 | 637 |

### 20 \| 1Q 2026 FORM 10-Q SLEEP NUMBER CORPORATION

### Comparison of Three Months Ended April 4, 2026 with Three Months Ended March 29, 2025

#### Net sales

Net sales for the three months ended April 4, 2026 of $319 million decreased 19% from $393 million for the same period

one year ago driven by lower volume and reduced store count. Macro environment and weather conditions in January and

early February in the three months ended April 4, 2026 had a significant negative impact on net sales. The net sales

change consisted primarily of a 16% Total Retail comparable sales decrease.

The $74 million net sales decrease compared with the same period one year ago was comprised of the following: (i) a

$54 million decrease in Total Retail comparable net sales; (ii) a $7 million decrease from online, phone and chat; and (iii) a

$13 million decrease from net store closings and other. Total Retail mattress unit sales decreased 19% compared with the

prior year. Total Retail average revenue per mattress unit increased to $6,021, compared with $5,992 in the prior-year

period.

#### Gross profit

Gross profit of $185 million for the three months ended April 4, 2026 decreased by $56 million, or 23%, compared with

$241 million for the same period one year ago. The gross profit margin totaled 57.9% of net sales for the three months

ended April 4, 2026, compared to 61.2% in the prior-year comparable period.

The current-year gross profit margin decrease of 3.3 ppt was affected by the following items: (i) an unfavorable product

mix decreased the rate by 1.4 ppt; (ii) unfavorable cost variances and other non-mattress unit sales and warranty related

revenue deleveraged the rate by 1.4 ppt; and (iii) higher discounts on close-out models deleveraged the rate by 0.5 ppt.

#### Sales and marketing expenses

Sales and marketing expenses for the three months ended April 4, 2026 were $161 million, or 50.4% of net sales,

compared with $189 million, or 48.1% of net sales, for the same period one year ago. The current-year sales and

marketing expenses rate increase of 2.3 ppt. was primarily due to the deleveraging impact of an 19% net sales decline,

partially offset by a 15% decrease in sales and marketing expenses including a 32% lower media spend.

#### General and administrative expenses

General and administrative (G&A) expenses totaled $34 million, or 10.5% of net sales, for the three months ended April 4,

2026, compared with $39 million, or 9.8% of net sales, in the prior-year period. The changes in G&A expenses consisted

mainly of: (i) a $3 million decrease in employee compensation; (ii) a $2 million year-over-year decrease in company-wide,

performance-based incentive compensation; and (iii) a $1 million decrease in depreciation and amortization; offset by (iv)

a $1 million increase in professional and consulting fees. The G&A expenses rate increased by 0.7 ppt. in the current-year

period, compared with the same period one year ago due to the items discussed above offset by the deleveraging impact

of lower net sales.

#### Research and development expenses

Research and development (R&D) expenses totaled $5 million for the three months ended April 4, 2026, compared with

$11 million with the same period one year ago. While the Company’s consumer innovation pipeline remains robust, it is re-

prioritizing R&D resources in this highly constrained environment. Moving forward, the Company’s innovation agenda will

focus on maintaining and improving the Company’s core technologies and introducing additional advancements, while

driving costs out of the product.

#### Interest expense, net

Interest expense, net totaled $13 million for the three months ended April 4, 2026, compared to $11 million for the same

period one year ago. The increase was due to an increase in the average debt outstanding compared to the same period

one year ago offset slightly by a lower weighted-average interest rate.

### 21 \| 1Q 2026 FORM 10-Q SLEEP NUMBER CORPORATION

#### Restructuring Costs

Restructuring costs for the three months ended April 4, 2026 were $22 million, compared with $0.1 million for the same

period one year ago. Charges incurred related to this initiative were comprised of contract termination costs, severance

and employee-related benefits, professional fees and other, and asset impairment charges. These costs are included in

the restructuring costs line in the Company’s condensed consolidated statement of operations. The Company expects an

additional $2 million of restructuring costs to be incurred through the remainder of 2026, primarily due to severance and

employee-related benefits, contract termination costs, and asset impairment charges. See Note 12, *Restructuring Costs,*

of the Notes to Condensed Consolidated Financial Statements included in Part I, Item 1, *Financial Information*, of this

Quarterly Report on Form 10-Q for further information on restructuring costs.

#### Income tax expense (benefit)

Income tax expense was $0.3 million for the three months ended April 4, 2026, compared with a benefit of $0.6 million for

the same period one year ago. The change in income tax expense was primarily due to state tax expense and discrete

items recognized in the three months ended April 4, 2026, while federal tax losses did not create a benefit due to the

deferred tax valuation allowance.

The Company evaluates its deferred income taxes on a quarterly basis to determine if valuation allowances are required.

As part of this evaluation, the Company assess whether valuation allowances should be established for any deferred tax

assets that are not considered more likely than not to be realized, using all available evidence, both positive and negative.

This assessment considers, among other matters, the nature, frequency, and severity of historical losses, forecasts of

future profitability, taxable income in available carryback periods and tax planning strategies. In making such judgments,

significant weight is given to evidence that can be objectively verified. On the basis of this evaluation, as of April 4, 2026, a

valuation allowance of $55 million has been recorded to recognize only a portion of the deferred tax asset that is more

likely than not to be realized. The Company continues to assess the need for the valuation allowance and will make

adjustments when appropriate.

### Liquidity and Capital Resources

#### Going Concern Considerations

The Company’s financial statements have been prepared under the assumption that the Company will continue as a going

concern, which contemplates the realization of assets and satisfaction of liabilities in the normal course of business for the

foreseeable future.

Historically, the Company has relied principally on liquidity generated from operating activities to fund the Company’s day-

to-day operations and service its debt. The Company has a history of net losses and negative operating cash flows and

expects to continue to incur additional losses in the future. Although the Company continues to pursue its turnaround

strategy “Sleep Number Shifts,” centered on product, marketing and distribution, as well as ongoing cost savings and

operating efficiencies, to reignite growth and increase financial resilience, the timing and realization of its turnaround

strategy cannot be guaranteed to ensure sufficient cash flow is generated to provide liquidity to meet the Company’s

obligations. While the Company was able to amend its Credit Agreement to provide that the lenders will forbear from

exercising certain rights and remedies in respect to certain events of default under the Credit Agreement (the “Specified

Defaults”) through the first week ending after July 1, 2026, and add a $25 million term loan facility with a maturity date of

June 30, 2026, the Company was not able to amend covenants beyond July 1, 2026 and therefore the Company

anticipates that it will not remain in compliance with the financial covenants of its Credit Agreement for the next twelve

months. These conditions and events raise substantial doubt about the Company’s ability to continue as a going concern.

Management’s plan to address the substantial doubt about the Company’s ability to continue as a going concern, as

described above, includes the following ongoing actions:

- execute the Company’s turnaround strategy centered on product, marketing and distribution with ongoing cost

savings and operating efficiencies to reignite growth and increase financial resilience;

- following the recent amendment of the Credit Agreement, the Company continues to engage with lenders to fulfill

the Company’s obligations under the credit facility and other provisions as needed; and

- work with financial advisors to negotiate with the lenders and identify and secure additional capital options,

alternative financing arrangements, strategic alternatives, or other comprehensive solutions to address the

Company’s capital structure and leverage needs to return to growth and create long-term value.

### 22 \| 1Q 2026 FORM 10-Q SLEEP NUMBER CORPORATION

There can be no assurance of the Company’s ability to realize these plans. As a result, the Company has concluded that

management’s plans do not alleviate substantial doubt about the Company’s ability to continue as a going concern for at

least one year from the date of issuance of these financial statements.

The consolidated financial statements do not include any adjustments relating to the recoverability and classification of

recorded asset amounts or the amounts and classification of liabilities that might result from the outcome of this

uncertainty.

#### Sources and Uses of Cash

Managing liquidity and capital resources is an important part of the Company’s commitment to deliver superior

shareholder value over time.

The Company’s primary sources of liquidity are cash flows provided by operating activities and cash available under its

$653 million revolving credit facility, as amended. As of April 4, 2026, the Company did not have any off-balance sheet

financing other than its $8 million in outstanding letters of credit. As discussed above in *Going Concern Considerations,*

the cash anticipated to be generated from ongoing operations and cash available under its Credit Agreement are not

expected to be sufficient to generate adequate liquidity to meet the Company’s obligations over the next twelve months.

The Company’s credit facility, as amended, is for general corporate purposes and to meet seasonal working capital

requirements. The credit facility, as amended, provides the lenders with a collateral security interest in substantially all of

the Company’s assets and those of its subsidiaries and requires the Company to comply with, among other things, a

maximum net leverage ratio and a minimum interest coverage ratio.

On November 4, 2025, the Company amended the Credit Agreement. The amendment, among other things: (a) extended

the maturity date of the Credit Agreement to December 3, 2027; (b) reduced the revolving credit facility from $485 million

to $475 million, which decreases further to $465 million on July 31, 2026; (c) replaced the leverage-based pricing grids

used to determine the Applicable Margin and Applicable Commitment Fee Rate (each as defined in the Credit Agreement)

in favor of (I) with respect to Applicable Margin for Term SOFR Loans, 4.25% starting January 1, 2027 and continuing

thereafter, and (II) with respect to the Applicable Commitment Fee Rate, 0.75% starting January 1, 2027 and continuing

thereafter; (d) on each Regularly Scheduled Payment Date (as defined in the Credit Agreement) occurring on and after

March 31, 2027, increases the amortization of outstanding term loans an additional $1,250,000 (for an aggregate

scheduled principal payment of $3,750,000); (e) terminated the accordion feature; (f) adjusted the permissible maximum

Net Leverage Ratio (as defined in the Credit Agreement) to (I) 4.75 to 1.00 for the quarterly reporting period ending April 4,

2026, (II) 4.80 to 1.00 for the quarterly reporting period ending July 4, 2026, and (III) 4.00 to 1.00 for each quarterly

reporting period thereafter; (g) adjusts the Liquidity financial covenant so that the Company must ensure that liquidity is no

lower than and $40 million for each monthly reporting period; (h) adjusts the permissible minimum Interest Coverage Ratio

to (I) 2.10 to 1.00 for the quarterly reporting periods ending January 3, 2026 and April 4, 2026, (II) 1.80 to 1.00 for the

quarterly reporting period ending July 4, 2026, (III) 2.10 to 1.00 for the reporting period ending October 3, 2026, and (IV)

2.20 to 1.00 for each quarterly reporting period occurring thereafter; (i) adds a new quarterly minimum EBITDA covenant

test that begins for the quarterly reporting period ending April 4, 2026; (j) adjusts the consolidated EBITDA calculation to

include an addback for certain expenses and costs incurred for the trailing twelve months for discontinued operations,

downsized functions and employment expenses for laid-off employees; and (k) provides for additional and more frequent

reporting requirements. In connection with the amendment, the Company also agreed to pay the lenders certain

amendment fees and to reimburse the lenders for certain expenses.

On April 27, 2026, the Company entered into a Forbearance Agreement and Thirteenth Amendment (the “Thirteenth

Amendment”) amending the Credit Agreement. The amendment, among other things: (a) adds a $25 million term loan

facility (the “2026 Term Loan”) that accrues interest at a rate per annum equal to the one-month term SOFR rate plus

8.00% and that matures on June 30, 2026, with a $5 million amortization payment due on June 1, 2026; (b) provides that

the lenders will forbear from exercising certain rights and remedies in respect of certain events of default under the Credit

Agreement (the “Specified Defaults”), subject to certain forbearance termination events; (c) requires that cash interest

payments in respect of all loans outstanding under the Credit Agreement be payable at least monthly; (d) permits the sale

of the Company’s claim for certain tariff refunds; (e) requires mandatory prepayments of the loans outstanding under the

Credit Agreement with any proceeds received from certain asset sales, equity issuances, debt incurrences, insurance

claims or condemnation or similar payments; (f) provides for additional and more frequent reporting requirements; (g)

adjusts the minimum liquidity financial covenant such that it does not apply from April 27, 2026 until the last Business Day

of the first week ending after July 1, 2026; (h) requires that the Company not permit disbursements or new draws under

### 23 \| 1Q 2026 FORM 10-Q SLEEP NUMBER CORPORATION

the revolving credit facility outstanding under the Credit Agreement (the “Revolving Facility”) to exceed an agreed

permitted variance amount; and (i) requires the Company to satisfy certain milestones, including milestones relating to the

Company’s efforts to consummate a strategic transaction that is designed to maximize enterprise value and provide for

payment in full of the obligations under the Credit Agreement. Following such amendment, the Company was in

compliance with all covenants (other than with respect to the Specified Defaults).

In connection with the Thirteenth Amendment, (i) on April 27, 2026, the 2026 Term Loan was fully funded and the

Company also drew down $2.7 million of revolving loans under the Revolving Facility, such that the aggregate principal

amount of outstanding revolving loans was $447.2 million, and (ii) the Company agreed to pay the lenders certain

amendment fees and to reimburse the lenders for certain expenses.

The Company’s management believes that its existing cash on hand combined with its anticipated future net losses may

be insufficient to fund its operations and debt obligations for at least the next 12 months. The Company’s management

has concluded that there is substantial doubt about the Company’s ability to continue as a going concern, which is not

alleviated, for one year from the date of issuance of this Quarterly Report on Form 10-Q. The Company’s future capital

requirements will depend on many factors, including, but not limited to, amending or waiving financial covenants of the

Credit Agreement, the successful execution of any future financing arrangements, its ability to achieve cost efficiencies

and the success of its turnaround strategy. To the extent that the Company’s existing cash balance and ongoing cash from

operations is insufficient to fund its future activities, the Company may need to raise additional funds through public or

private equity or debt financing, and such funds may not be available on acceptable terms. If sufficient cash from

operations or external funding is not available, the Company would be unable to adequately fund its business plan and the

Company’s business, results of operations, cash flows and financial condition would be materially and adversely affected.

At April 4, 2026, the Company had an aggregate amount of $606 million of borrowings outstanding under its credit

agreement, including $178 million in outstanding term loans and $428 million outstanding under its revolving credit facility,

along with $8 million in outstanding letters of credit. Availability under the revolving credit facility amounted to $39 million.

At April 4, 2026, the weighted-average interest rate on borrowings under the credit facility was 7.8%. Following such

amendment, the Company was in compliance with all covenants (other than with respect to the Specified Defaults).

#### Cash Flow Information

Cash and cash equivalents totaled $1 million and $2 million at April 4, 2026 and January 3, 2026, respectively. The

following table summarizes cash flows (dollars in millions). Amounts may not add due to rounding differences:

| Total cash (used in) provided by: | Three Months Ended April 4, 2026 | March 29, 2025 |
| --- | ---: | ---: |
| Operating activities | $(7.8) | $(2.6) |
| Investing activities | (5.4) | (4.6) |
| Financing activities | 13.0 | 7.0 |
| Net decrease in cash and cash equivalents | $(0.2) | $(0.3) |

Cash used in operating activities for the three months ended April 4, 2026 was $8 million, compared with $3 million for the

three months ended March 29, 2025. Significant components of the year-over-year change in cash provided by operating

activities included: (i) a $42 million year-over-year increase in net loss; (ii) a $5 million fluctuation in accounts payable due

to timing of payments; a $5 million change in prepaid expenses and other current assets; offset by (iv) a $18 million

fluctuation in the impairment of lease and store related assets; (v) a $14 million fluctuation in the amount of compensation

and benefits accrued and timing of the related payments resulting from year-over-year changes in Company-wide

performance-based incentive compensation; a $10 million fluctuation in customer prepayments, and (iii) a $3 million

fluctuation in inventory balances.

Net cash used in investing activities for the both the three months ended April 4, 2026 and March 29, 2025 was $5 million,

and was due to the purchases of property and equipment.

Net cash provided by financing activities was $13 million for the three months ended April 4, 2026, compared with $7

million for the same period one year ago. Short-term borrowings increased by $14 million during the current-year period

### 24 \| 1Q 2026 FORM 10-Q SLEEP NUMBER CORPORATION

due to a $17 million increase in borrowings under the revolving credit facility to $606 million and a $4 million decrease in

book overdrafts, which are included in the net change in short-term borrowings. During both the three months ended

April 4, 2026 and March 29, 2025, the Company repurchased $0.5 million of its stock in connection with the vesting of

employee restricted stock awards.

#### Share Repurchases

In the second quarter of fiscal 2022, the Company suspended share repurchases under its Board-approved share

repurchase program. At April 4, 2026, there was $348 million remaining authorization under the Board-approved

$600 million share repurchase program. There is no expiration date governing the period over which the Company can

repurchase shares. The Company made no share repurchases under its Board-approved share repurchase program in

either period.

### Non-GAAP Data Reconciliations

#### Earnings before Interest, Taxes, Depreciation and Amortization (Adjusted EBITDA)

The Company defines earnings before interest, taxes, depreciation and amortization (Adjusted EBITDA) as net loss plus:

income tax expense (benefit), interest expense, depreciation and amortization, stock-based compensation, restructuring

costs, other non-recurring items and asset impairments. Management believes Adjusted EBITDA is a useful indicator of

the Company’s financial performance and its ability to generate cash from operating activities. The Company’s definition of

Adjusted EBITDA may not be comparable to similarly titled definitions used by other companies. The table below

reconciles Adjusted EBITDA, which is a non-GAAP financial measure, to the comparable GAAP financial measure.

Adjusted EBITDA calculations are as follows (in thousands):

|  | Three Months Ended April 4, 2026 | March 29, 2025 | Trailing-Twelve Months Ended April 4, 2026 | March 29, 2025 |
| --- | ---: | ---: | ---: | ---: |
| Net loss | $(50,297) | $(8,646) | $(173,609) | $(21,498) |
| Income tax expense (benefit) | 338 | (585) | 36,907 | (6,472) |
| Interest expense | 13,103 | 11,081 | 51,404 | 47,150 |
| Depreciation and amortization | 11,126 | 14,406 | 49,889 | 62,240 |
| Stock-based compensation | 2,827 | 3,951 | 5,158 | 11,278 |
| Restructuring costs(1) | 21,736 | 60 | 72,373 | 7,526 |
| Other non-recurring items(2) | 6,917 | 1,774 | 19,841 | 2,772 |
| Asset impairments | — | — | — | 1,220 |
| Adjusted EBITDA | $5,750 | $22,041 | $61,963 | $104,216 |

(1) Represents costs related to business restructuring actions. See Note 12, *Restructuring Costs*, of the Notes to Condensed Consolidated Financial

Statements included in Item 1, Financial Statements, of this Quarterly Report on Form 10-Q for further information on restructuring costs.

(2) Non‑recurring costs represent discrete, non‑operational items, including obsolete inventory associated with the Company’s product transition,

strategic alternative legal and advisory fees, executive transition and search fees, proxy contest costs, public debt issuance cost write-off, tax

matters and other non‑routine professional and bank fees. These amounts are treated as permitted add-backs in the calculation of Adjusted

EBITDA in accordance with the Company’s Credit Agreement.

### 25 \| 1Q 2026 FORM 10-Q SLEEP NUMBER CORPORATION

#### Free Cash Flow

The Company’s “free cash flow” data is considered a non-GAAP financial measure and is not in accordance with, or

preferable to, “net cash provided by operating activities,” or GAAP financial data. However, the Company is providing this

information as it believes it facilitates analysis for investors and financial analysts.

The following table summarizes free cash flow calculations (in thousands):

|  | Three Months Ended April 4, 2026 | March 29, 2025 | Trailing-Twelve Months Ended April 4, 2026 | March 29, 2025 |
| --- | ---: | ---: | ---: | ---: |
| Net cash used in operating activities | $(7,751) | $(2,626) | $(8,408) | $(9,228) |
| Subtract: Purchases of property and equipment | 5,441 | 4,599 | 15,249 | 18,796 |
| Free cash flow | $(13,192) | $(7,225) | $(23,657) | $(28,024) |

#### Return on Invested Capital (Adjusted ROIC)

Adjusted ROIC is a financial measure the Company uses to determine how efficiently it deploys its capital. It quantifies the

return the Company earns on its adjusted invested capital. Management believes Adjusted ROIC is also a useful metric

for investors and financial analysts. The Company computes Adjusted ROIC as outlined below. Its definition and

calculation of Adjusted ROIC may not be comparable to similarly titled definitions and calculations used by other

companies.

The tables below reconcile adjusted net operating profit after taxes (Adjusted NOPAT) and total adjusted invested capital,

which are non-GAAP financial measures, to the comparable GAAP financial measures (in thousands):

| Adjusted net operating profit after taxes (Adjusted NOPAT) | Trailing-Twelve Months Ended April 4, 2026 | March 29, 2025 |
| --- | ---: | ---: |
| Operating income | $(85,299) | $19,180 |
| Add: Operating lease expense (1) | 23,832 | 26,098 |
| Less: Income taxes (2) | 7,902 | (10,022) |
| Adjusted NOPAT | $(53,565) | $35,256 |
| Average adjusted invested capital |  |  |
| Total deficit | $(626,317) | $(456,844) |
| Add: Long-term debt (3) | 605,720 | 557,921 |
| Add: Operating lease obligations (4) | 348,037 | 376,909 |
| Total adjusted invested capital at end of period | $327,440 | $477,986 |
| Average adjusted invested capital (5) | $408,437 | $487,361 |
| Adjusted return on invested capital (Adjusted ROIC) (6) | (13.1%) | 7.2% |

(1) Represents the interest expense component of lease expense included in the Company’s financial statements under ASC 842, *Leases.*

(2) Reflects annual effective income tax rates, before discrete adjustments, of 12.9% and 22.1% for April 4, 2026 and March 29, 2025, respectively.

(3) Long-term debt includes existing finance lease liabilities.

(4) Reflects operating lease liabilities included in the Company’s financial statements under ASC 842.

(5) Average adjusted invested capital represents the average of the last five fiscal quarters’ ending adjusted invested capital balances.

(6) Adjusted ROIC equals Adjusted NOPAT divided by average adjusted invested capital.

Note - the Company’s adjusted ROIC calculation and data are considered non-GAAP financial measures and are not in accordance with, or preferable

to, GAAP financial data. However, the Company is providing this information as it believes it facilitates analysis of the Company's financial performance

by investors and financial analysts.

GAAP - generally accepted accounting principles in the U.S.

### 26 \| 1Q 2026 FORM 10-Q SLEEP NUMBER CORPORATION

### Critical Accounting Policies

The Company discusses its critical accounting policies and estimates in *Management’s Discussion and Analysis of*

*Financial Condition and Results of Operations* in the Company’s Annual Report on Form 10-K for the fiscal year ended

January 3, 2026. There were no significant changes in the Company’s critical accounting policies since the end of fiscal

2025.

### 27 \| 1Q 2026 FORM 10-Q SLEEP NUMBER CORPORATION

## Market risk

As filed, 474 characters.

The Company is exposed to changes in market-based short-term interest rates that will impact net interest expense. If

overall interest rates were one percentage point higher than current rates, annual net income would decrease by

$5.3 million based on the $606 million of borrowings under the credit facility at April 4, 2026. The Company does not

manage the interest-rate volatility risk of borrowings under the credit facility through the use of derivative instruments.

## Controls and procedures

As filed, 1,656 characters.

### Conclusions Regarding the Effectiveness of Disclosure Controls and Procedures

The Company maintains disclosure controls and procedures, as defined in Exchange Act Rule 13a-15(e), that are

designed to ensure that information required to be disclosed by the Company in the reports that it files or submits under

the Securities Exchange Act of 1934, as amended, is recorded, processed, summarized and reported within the time

periods specified in the Securities and Exchange Commission’s rules and forms, and that such information is accumulated

and communicated to the Company’s management, including its principal executive officer and principal financial officer,

or persons performing similar functions, as appropriate to allow timely decisions regarding required disclosure. The

Company’s management, with the participation of its principal executive officer and principal financial officer, evaluated the

effectiveness of the design and operation of the Company’s disclosure controls and procedures as of the end of the period

covered by this quarterly report. Based on this evaluation, its principal executive officer and principal financial officer

concluded that the Company’s disclosure controls and procedures were effective as of the end of the period covered by

this quarterly report.

### Changes in Internal Control

There were no changes in the Company’s internal control over financial reporting during the fiscal quarter ended April 4,

2026, that have materially affected, or are reasonably likely to materially affect, the Company’s internal control over

financial reporting.

### 28 \| 1Q 2026 FORM 10-Q SLEEP NUMBER CORPORATION

## Risk factors

As filed, 1,003 characters.

The Company’s business, financial condition and operating results are subject to a number of risks and uncertainties,

including both those that are specific to the Company’s business and others that affect all businesses operating in a global

environment. Investors should carefully consider the information in this report under the heading, *Management’s*

*Discussion and Analysis of Financial Condition and Results of Operations*, and also the information under the heading,

*Risk Factors*, in the Company’s most recent Annual Report on Form 10-K and in subsequent Quarterly Reports on

Form 10-Q. The risk factors discussed in the Annual Report on Form 10-K and in subsequent Quarterly Reports on Form

10-Q including this Quarterly Report on Form 10-Q do not identify all risks that the Company faces because its business

operations could also be affected by additional risk factors that are not presently known to the Company or that it currently

considers to be immaterial to its operations.

Filed May 12, 2026.
Source: SEC EDGAR, the filing index for accession 0000827187-26-000041. Last ingested by Listed: Oct 24, 2026, 14:57 ET. No prices; not investment advice.
